# Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer

Source: https://onco.cc/trials/nct06601283/  
OnCo record `nct06601283` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial in pancreatic cancer, run by Fudan University, now recruiting.

## Summary

Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer is a phase 2/3, interventional study registered as NCT06601283 by Fudan University, with a registry enrolment figure of 50 participants, started 2024-11-22 and due to reach its primary completion in 2026-11-22. Interventions recorded: Vitmain C plus herbal medicine. Conditions listed: Pancreatic Cancer. Primary outcome: Rate of anemia. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed metastatic pancreas adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06601283
- Phase: 2/3
- Setting: Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
- Sponsor: Fudan University
- Enrolled: 50

## Sources

- ClinicalTrials.gov NCT06601283: https://clinicaltrials.gov/study/NCT06601283

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06601283.json